NCT07490132RecruitingNot Applicable
Endoscopic Retrograde Cholangiopancreatography Patient Registry
Methodist Health System1 site in 1 country100 target enrollmentStarted: February 1, 2026Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Methodist Health System
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Underwent ERCP
Study Overview
Brief Summary
The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.
Detailed Description
The primary objective of this study is to provide a mechanism to store the following information about patients undergoing ERCPs at Methodist Dallas Medical Center. This registry will be permissive of quality improvement and research studies.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Other
Eligibility Criteria
- Ages
- 15 Years to — (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients >15 years Included in MDI's Registry Underwent ERCP between January 1, 2000 through December 31, 2025
Exclusion Criteria
- •Patients <15 years Patients in which cannulation was via a surgical anastomosis Patients in which cannulation was not attempted due to gastric outlet obstruction, the main papilla not found, or the minor papilla was not found will be excluded.
Outcomes
Primary Outcomes
Underwent ERCP
Time Frame: 25 years
Patients undergoing ERCPs at Methodist Dallas Medical Center.
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Not yet recruiting
Not Applicable
Indian National Study to Assess Incidence and Severity of Post-ERCP Pancreatitis After Following SOPNCT07329790Asian Institute of Gastroenterology, India2,366
Active, not recruiting
Not Applicable
Efficacy and Safety of a Novel ERCP Robot in the Treatment of Common Bile Duct StoneNCT07368335The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School200
Not yet recruiting
Not Applicable
Efficacy and Safety of Anricofen Combined With Ciprofol for Deep Sedation in Elderly Patients Undergoing ERCPNCT07376577The First Affiliated Hospital of Xinxiang Medical College141
Completed
Not Applicable
Role of Prophylactic Aggressive Hydration to Prevent Post-ERCP PancreatitisBiliary ObstructionNCT07417020Lahore General Hospital126
Not yet recruiting
Not Applicable
Pre-cut Versus Intentional Double Guidewire for ERCP Cannulation: Prospective, Randomized Controlled TrialNCT07329803Asian Institute of Gastroenterology, India840